Stocks and Investing Stocks and Investing
Tue, April 6, 2021
Mon, April 5, 2021
Sun, April 4, 2021
Thu, April 1, 2021
Wed, March 31, 2021
Tue, March 30, 2021

Stephen Willey Maintained (ABCL) at Strong Buy with Decreased Target to $55 on, Mar 30th, 2021


Published on 2024-10-27 16:04:28 - WOPRAI, Stephen Willey
  Print publication without navigation


Stephen Willey of Stifel, Maintained "AbCellera Biologics Inc." (ABCL) at Strong Buy with Decreased Target from $59 to $55 on, Mar 30th, 2021.

Stephen has made no other calls on ABCL in the last 4 months.



There are 4 other peers that have a rating on ABCL. Out of the 4 peers that are also analyzing ABCL, 0 agree with Stephen's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Stephen


  • Puneet Souda of "SVB Leerink" Maintained at Buy with Increased Target to $52 on, Monday, February 8th, 2021
  • Tiago Fauth of "Credit Suisse" Initiated at Buy on, Tuesday, January 5th, 2021
  • Do Kim of "BMO Capital" Initiated at Buy and Held Target at $48 on, Tuesday, January 5th, 2021
  • Gal Munda of "Berenberg" Initiated at Strong Buy and Held Target at $53 on, Tuesday, January 5th, 2021